| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NUVASIVE INC | EVP, Chief Commercial Officer | Common Stock | 7.21K | $308K | $42.67 | Mar 1, 2022 | Direct |
| Orthofix Medical Inc. | President & CEO, Director | Common Stock | 1K | $13.7K | $13.65 | Jan 8, 2024 | Direct |
| Orthofix Medical Inc. | President & CEO, Director | Employee Stock Option (right to buy) | 392K | Jan 8, 2024 | Direct | ||
| NUVASIVE INC | EVP, Chief Commercial Officer | RSUs | 11K | Mar 1, 2022 | Direct | ||
| NUVASIVE INC | EVP, Chief Commercial Officer | PRSUs | 0 | Mar 1, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| OFIX | Orthofix Medical Inc. | Jan 8, 2024 | 0 | $0 | 3/A | Jan 23, 2024 | President & CEO, Director |
| OFIX | Orthofix Medical Inc. | Jan 8, 2024 | 2 | $1.88M | 4 | Jan 10, 2024 | President & CEO |
| OFIX | Orthofix Medical Inc. | Jan 8, 2024 | 0 | $0 | 3 | Jan 10, 2024 | President & CEO |
| NUVA | NUVASIVE INC | Mar 1, 2022 | 5 | -$168K | 4 | Mar 3, 2022 | EVP, Chief Commercial Officer |
| NUVA | NUVASIVE INC | Feb 10, 2022 | 1 | $0 | 4 | Feb 14, 2022 | EVP, Chief Commercial Officer |
| NUVA | NUVASIVE INC | Sep 1, 2021 | 3 | -$30.5K | 4 | Sep 3, 2021 | EVP, Chief Commercial Officer |
| NUVA | NUVASIVE INC | May 7, 2021 | 1 | -$232K | 4 | May 11, 2021 | EVP, Global Business Units |